NCT00094640已完成1 期
Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 8
研究概览
简要总结
The goals of this study are to:
Determine the blood levels of intramuscular (IM) olanzapine depot in patients at different points in time after an injection, and compare these levels to the amount of olanzapine in the blood of patients after treated by oral administration with Zyprexa (olanzapine) tablets or by intramuscular administration with Zyprexa IntraMuscular (olanzapine for injection).
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 76 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have schizophrenia or schizoaffective disorders.
- •Each patient must have a level of understanding sufficient to complete all tests and examinations required by the protocol, and to provide informed consent.
- •Patient must not have participated in a clinical trial of another investigational drug, including olanzapine, within 1 month (30 days) prior to study entry.
- •Female patients must not be pregnant or breast-feeding.
- •Patients must not be experiencing acute, serious, or unstable medical conditions other than schizophrenia or schizoaffective disorder.
排除标准
- 未提供
研究者
研究点 (8)
Loading locations...
相似试验
已完成
3 期
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaSchizophreniaNCT00088478Eli Lilly and Company402
已完成
3 期
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaAgitationSchizophreniaSchizoaffective DisorderNCT00797277National Taiwan University Hospital67
Unknown
不适用
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderSchizoaffective DisordersSchizophreniaNCT01389908Shalvata Mental Health Center2
尚未招募
3 期
A Study of Olanzapine in Patients With Acute AgitationAcute AgitationNCT05803642Qilu Pharmaceutical Co., Ltd.318
进行中（未招募）
不适用
An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder - HGKBSchizophrenia or Schizoaffective DisorderEUCTR2004-000986-37-BEEli Lilly and Company Limited1,000